ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Percentage of Revenue and Accounts Receivable by Customer (Details) - Customer Concentration Risk	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Consolidated revenue
Concentration Risk [Line Items]
Total	100.00%	100.00%
Accounts receivable related to product sales
Concentration Risk [Line Items]
Total	100.00%	100.00%
AmerisourceBergen Corporation | Consolidated revenue
Concentration Risk [Line Items]
Total	35.00%	28.00%
AmerisourceBergen Corporation | Accounts receivable related to product sales
Concentration Risk [Line Items]
Total	57.00%	21.00%
McKesson Corporation | Consolidated revenue
Concentration Risk [Line Items]
Total	21.00%	28.00%
McKesson Corporation | Accounts receivable related to product sales
Concentration Risk [Line Items]
Total	12.00%	25.00%
Cardinal Health | Consolidated revenue
Concentration Risk [Line Items]
Total	18.00%	23.00%
Cardinal Health | Accounts receivable related to product sales
Concentration Risk [Line Items]
Total	14.00%	42.00%
Other significant customer | Consolidated revenue
Concentration Risk [Line Items]
Total	10.00%	4.00%
Other significant customer | Accounts receivable related to product sales
Concentration Risk [Line Items]
Total	10.00%	4.00%
All others | Consolidated revenue
Concentration Risk [Line Items]
Total	16.00%	17.00%
All others | Accounts receivable related to product sales
Concentration Risk [Line Items]
Total	7.00%	8.00%